Complete reference list (PDF 1191 KB) - Department of Health and ...

104. Crawford NW, Clothier HJ, Elia S, et al. Syncope and seizures following human papillomavirus
vaccination: a retrospective case series. Medical Journal of Australia 2011;194:16-8.
105. van‘t Klooster TM, Kemmeren JM, van der Maas NA, de Melker HE. Reported adverse events in
girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in
the Netherlands. Vaccine 2011;29:4601-7.
106. Gee J, Naleway A, Shui I, et al. Monitoring the safety of quadrivalent human papillomavirus
vaccine: findings from the Vaccine Safety Datalink. Vaccine 2011;29:8279-84.
107. Australian Government Department of Health and Ageing, Therapeutic Goods Administration.
Gardasil (human papillomavirus vaccine). 24 June 2010. Available at:
http://www.tga.gov.au/safety/alerts-medicine-gardasil-070624.htm (accessed May 2011).
4.7 Influenza
References
1. Wright PF, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe DM, Howley PM, Griffin DE,
et al., eds. Fields virology. 5th ed. Philadelphia, PA: Lippincott Williams and Wilkins, 2007.
2. Australian Government Department of Health and Ageing. Australian influenza surveillance
report. No. 9, 2011. Reporting period: 9 July to 22 July 2011. Available at:
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-ozflu-no9-11.htm (accessed
July 2011).
3. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than
5 years: a 25-year prospective study. Journal of Infectious Diseases 2002;185:147-52.
4. Hurwitz ES, Haber M, Chang A, et al. Effectiveness of influenza vaccination of day care children
in reducing influenza-related morbidity among household contacts. JAMA 2000;284:1677-82.
5. Lester-Smith D, Zurynski YA, Booy R, et al. The burden of childhood influenza in a tertiary
paediatric setting. Communicable Diseases Intelligence 2009;33:209-15.
6. Iskander M, Kesson A, Dwyer D, et al. The burden of influenza in children under 5 years admitted
to The Children‘s Hospital at Westmead in the winter of 2006. Journal of Paediatrics and Child
Health 2009;45:698-703.
7. Newall AT, Scuffham PA. Influenza-related disease: the cost to the Australian healthcare system.
Vaccine 2008;26:6818-23.
8. Newall AT, Wood JG, MacIntyre CR. Influenza-related hospitalisation and death in Australians
aged 50 years and older. Vaccine 2008;26:2135-41.
9. Chiu C, Dey A, Wang H, et al. Vaccine preventable diseases in Australia, 2005 to 2007.
Communicable Diseases Intelligence 2010;34 Suppl:ix-S167.
10. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United
States. JAMA 2004;292:1333-40.
11. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in
young children. New England Journal of Medicine 2006;355:31-40.
12. Savulescu C, Valenciano M, de Mateo S, Larrauri A, cycEVA Study Team. Estimating the
influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza
surveillance network – pilot case-control studies using different control groups, 2008–2009
season, Spain. Vaccine 2010;28:2903-7.
13. Dean AS, Moffatt CR, Rosewell A, et al. Incompletely matched influenza vaccine still provides
protection in frail elderly. Vaccine 2010;28:864-7.
14. World Health Organization (WHO). Global Alert and Response (GAR). Pandemic (H1N1) 2009 –
update 112. 2010. Available at: http://www.who.int/csr/don/2010_08_06/en/index.html (accessed
June 2012).
15. Australian Government Department of Health and Ageing. Australian influenza surveillance
report. No. 44, 2010, reporting period: 30 October – 5 November 2010. Available at:
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-ozflu-no44-10.htm (accessed
July 2011).
16. Australian Government Department of Health and Ageing. Review of Australia‘s health sector
response to pandemic (H1N1) 2009: lessons identified. 2011. Available at: